GOLDMAN SACHS GROUP INC - 31 Mar 2025 SCHEDULE 13G Report for FATE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (FATE)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: FATE THERAPEUTICS, INC. Common Stock, par value $0.001 per share
Symbol: FATE
Shares outstanding: 115M shares
Disclosed Ownership: 8.49M shares
Ownership: 7.4%
Form type: SCHEDULE 13G
Filing time: 09 May 2025, 12:27:11 UTC
Date of event: 31 Mar 2025
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	7.4%	8.49M	0	8.49M	Name: AMEEN SOETAN	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	7.4%	8.49M	0	8.49M	Name: AMEEN SOETAN	Attorney-in-fact